معرفی
George Byrd Abercrombie serves as Adjunct Professor of Business Administration at Duke University's Fuqua School of Business since 2013, teaching second-year MBA candidates in the Health Sector Curriculum. His industry expertise spans pharmaceutical leadership and corporate governance.
Education:
- Bachelor of Pharmacy, University of North Carolina at Chapel Hill
- M.B.A., Harvard University (1993)
- Harvard Business School: Making Corporate Boards More Effective (2010)
His research focuses on healthcare management and pharmaceutical industry strategy, drawing from 30+ years of executive experience. He examines business development models in biopharmaceuticals and corporate governance frameworks, particularly through his advisory work with early-stage companies via Abercrombie Advisors LLC.
Professional Recognition:
- Appointed to North Carolina Board of Science, Technology and Innovation (2019) by Governor Roy Cooper
- Member of Duke University Psychiatry and Behavioral Sciences Advisory Board
- Board roles: Biocryst Pharmaceuticals (Audit/Commercialization Committees), Hessian Pharmaceuticals, Brickell Biotech
Abercrombie mentors MBA students through practical industry insights, emphasizing real-world applications in pharmaceutical commercialization. His advisory work with Innoviva, Inc. (2014-2018) and current board positions inform his teaching on strategic decision-making. He actively contributes to industry organizations including PhRMA and the Healthcare Institute of New Jersey.
Current leadership includes chairing Corporate Governance Committees for Biocryst Pharmaceuticals and Brickell Biotech, alongside advisory roles for the North Carolina GlaxoSmithKline Foundation.
